L.M. Kohn & Company Buys Shares of 2,224 Aflac Incorporated (NYSE:AFL)

L.M. Kohn & Company purchased a new stake in Aflac Incorporated (NYSE:AFL) in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 2,224 shares of the financial services provider’s stock, valued at approximately $249,000.

A number of other large investors have also made changes to their positions in AFL. Lazard Asset Management LLC grew its position in shares of Aflac by 19.4% in the first quarter. Lazard Asset Management LLC now owns 1,520 shares of the financial services provider’s stock valued at $130,000 after purchasing an additional 247 shares in the last quarter. Atria Investments Inc grew its position in shares of Aflac by 87.1% in the first quarter. Atria Investments Inc now owns 30,285 shares of the financial services provider’s stock valued at $2,600,000 after purchasing an additional 14,098 shares in the last quarter. GAMMA Investing LLC grew its position in shares of Aflac by 193.4% in the second quarter. GAMMA Investing LLC now owns 9,335 shares of the financial services provider’s stock valued at $834,000 after purchasing an additional 6,153 shares in the last quarter. Massmutual Trust Co. FSB ADV grew its position in shares of Aflac by 576.9% in the second quarter. Massmutual Trust Co. FSB ADV now owns 8,075 shares of the financial services provider’s stock valued at $721,000 after purchasing an additional 6,882 shares in the last quarter. Finally, DNB Asset Management AS grew its position in Aflac by 3.0% in the second quarter. DNB Asset Management AS now owns 100,015 shares of the financial services provider’s stock worth $8,932,000 after acquiring an additional 2,885 shares during the period. 67.44% of the stock is currently owned by hedge funds and other institutional investors.

Aflac Stock Down 0.1 %

Aflac stock opened at $114.00 on Friday. Aflac Incorporated has a 1-year low of $75.07 and a 1-year high of $115.50. The company has a debt-to-equity ratio of 0.32, a current ratio of 0.08 and a quick ratio of 0.08. The stock has a market cap of $63.33 billion, a PE ratio of 17.17, a P/E/G ratio of 2.18 and a beta of 0.96. The stock’s fifty day moving average is $111.23 and its two-hundred day moving average is $101.53.

Aflac (NYSE:AFL) last posted its quarterly earnings results on Wednesday, October 30th. The financial services provider reported $2.16 earnings per share for the quarter, beating analysts’ consensus estimates of $1.69 by $0.47. Aflac had a return on equity of 16.34% and a net margin of 22.02%. The company had revenue of $2.95 billion for the quarter, compared to analysts’ expectations of $4.30 billion. During the same period last year, the firm earned $1.84 earnings per share. Aflac’s quarterly revenue was down 40.4% on a year-over-year basis. On average, sell-side analysts expect that Aflac Incorporated will post 7.27 EPS for the current fiscal year.

Aflac Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, December 2nd. Shareholders of record on Wednesday, November 20th will be paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 1.75%. The ex-dividend date of this dividend is Wednesday, November 20th. Aflac’s dividend payout ratio is presently 30.12%.

Analyst Ratings Changes

Several brokerages recently weighed in on AFL. Wells Fargo & Company increased their price objective on Aflac from $106.00 to $107.00 and gave the stock an “equal weight” rating in a research report on Tuesday, November 5th. JPMorgan Chase & Co. increased their price objective on Aflac from $85.00 to $90.00 and gave the stock a “neutral” rating in a research report on Thursday, October 3rd. Bank of America increased their price objective on Aflac from $115.00 to $124.00 and gave the stock a “buy” rating in a research report on Thursday, October 10th. Morgan Stanley increased their price objective on Aflac from $91.00 to $98.00 and gave the stock an “equal weight” rating in a research report on Monday, August 19th. Finally, Piper Sandler increased their price objective on Aflac from $114.00 to $122.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 2nd. Three research analysts have rated the stock with a sell rating, ten have issued a hold rating and three have given a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $97.93.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.